Abstract
Thymosin α1 (Tα1) was widely used for the treatment of hepatitis (B and C) and several cancers. However, current production of Tα1 is difficultly meeting clinical needs. To develop a novel and safety approach for Tα1 production, we synthesized a Tα1 gene (124 bp) based on the plant codon usage bias and constructed a four-copy Tα1 gene concatemer (408 bp) by using isocaudamer technique. This 4 × Tα1 structure was cloned into plant binary expression vector pCAMBIA2300 with twin transfer deoxyribonucleic acids (T-DNAs) and integrated into lettuce genome via Agrobacterium-mediated transformation. Thirteen positive plants were identified by polymerase chain reaction and confirmed by Southern blot analysis, and 11 marker-free lettuce plants were obtained in T2 generation. The content of recombined Tα1 (rTα1) protein reached 1798.317 ± 87.312 ng/g in fresh leaves of transgenic lettuce. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay demonstrated that rTα1 protein stimulated mouse splenic lymphocyte proliferation in vitro. These data suggest that biologically active rTα1 was successfully expressed in marker-free transgenic lettuce, and this method could provide an alternative choice for large-scale production of Tα1 in the future.
Similar content being viewed by others
References
Basaran P, Rodríguez-Cerezo E (2008) Plant molecular farming: opportunities and challenges. Crit Rev Biotechnol 28:153–172
Billich A (2002) Thymosin alpha1. SciClone Pharmaceuticals. Curr Opin Investig Drugs 3:698–707
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Brodzik R, Glogowska M, Bandurska K, Okulicz M, Deka D, Ko K et al (2006) Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. Proc Natl Acad Sci USA 103:8804–8809
Chen PF, Zhang HY, Fu GF, Xu GX, Hou YY (2005) Overexpression of soluble human thymosin alpha 1 in Escherichia coli. Acta Biochim Biophys Sin (Shanghai) 37:147–151
Chen YH, Wang AX, Zhao LX, Shen GA, Cui LJ, Tang KX (2009) Expression of thymosin alpha1 concatemer in transgenic tomato (Solanum lycopersicum) fruits. Biotechnol Appl Biochem 52:303–312
Chupeau MC, Bellini C, Guerche P, Maisonneuve B, Vastra G, Chupeau Y (1989) Transgenic plants of lettuce Lactuca sativa obtained through electroporation of protoplasts. Biotechnology 7:503–508
Ciancio A, Rizzetto M (2010) Thymalfasin in the treatment of hepatitis B and C. Ann NY Acad Sci 1194:141–146
Cleri DJ, Ricketti AJ, Vernaleo JR (2007) Fever of unknown origin due to zoonoses. Infect Dis Clin North Am 21:963–996
Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, Peele CG et al (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 24:1591–1597
Daley M, Knauf VC, Summerfelt KR, Turner JC (1998) Co-transformation with one Agrobacterium tumefaciens strain containing two binary plasmids as a method for producing marker-free transgenic plants. Plant Cell Rep 17:489–496
Daniell H, Streatfield SJ, Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6:219–226
De Framond AJ, Back EW, Chilton WS, Kayes L, Chilton M (1986) Two unlinked T-DNAs can transform the same tobacco plant cell and segregate in the F1 generation. Mol Gen Genet 202:125–131
Depicker A, Herman L, Jacobs A, Schell J, Van Montagu M (1985) Frequencies of simultaneous transformation with different T-DNAs and their relevance to Agrobacterium/plant cell interaction. Mol Gen Genet 201:477–484
Fischer R, Emans N (2000) Molecular farming of pharmaceutical proteins. Transgenic Res 9:279–299
Fischer R, Twyman RM, Schillberg S (2003) Production of antibodies in plants and their use for global health. Vaccine 21:820–825
Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM (2004) Plant based production of biopharmaceuticals. Curr Opin Plant Biol 7:152–158
Garaci E, Favalli C, Pica F, Sinibaldi VP, Palamara AT, Matteucci C et al (2007) Thymosin alpha 1: from bench to beside. Ann NY Acad Sci 1112:225–234
Goldstein AL, Goldstein AL (2009) From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther 9:593–608
Goldstein AL, Low TL, McAdoo M, McClure J, Thurman GB, Rossio J et al (1977) Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci USA 74:725–729
Hadden JW (2001) Aspects of the immunopharmacology of thymosin Tα1. Clin Appl Immunol Rev 1:187–191
Horn ME, Woodard SL, Howard JA (2004) Plant molecular farming: systems and products. Plant Cell Rep 22:711–720
Hull AK, Criscuolo CJ, Mett V, Groen H, Steeman W, Westra H et al (2005) Human-derived, plant-produced monoclonal antibody for the treatment of anthrax. Vaccine 23:2082–2086
Joshi L, Lopez LC (2005) Bioprospecting in plants for engineered proteins. Curr Opin Plant Biol 8:223–226
Komari T, Hiei Y, Saito Y, Murai N, Kumashiro T (1996) Vectors carrying two separate T-DNAs for co-transformation of higher plants mediated by Agrobacterium tumefaciens and segregation of transformants free from selection markers. Plant J 10:165–174
Lico C, Chen Q, Santi L (2008) Viral vectors for production of recombinant proteins in plants. J Cell Physiol 216:366–377
Liénard D, Sourrouille C, Gomord V, Faye L (2007) Pharming and transgenic plants. Biotechnol Annu Rev 13:115–147
Ma JKC, Drake PMW, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805
Marx J (2007) Behavioral genetics. Evidence linking DISC1 gene to mental illness builds. Science 316:682–683
McCabe MS, Garratt LC, Schepers F, Jordi WJ, Stoopen GM, Davelaar E et al (2001) Effects of P(SAG12)-IPT gene expression on development and senescence in transgenic lettuce. Plant Physiol 127:505–516
Michelmore RW, Marsh E, Seeley S, Landry BS (1987) Transformation of lettuce mediated by Agrobacterium tumefaciens. Plant Cell Rep 6:439–442
Moscarella S, Buzzelli G, Romanelli RG, Monti M, Giannini C, Careccia G et al (1998) Interferon and thymosin combination therapy in naïve patients with chronic hepatitis C: preliminary results. Liver 18:366–369
Naylor PH, Hadden JW (2010) Preclinical studies with IRX-2 and thymosin α1 in combination therapy. Ann NY Acad Sci 1194:162–168
Okubara PA, Arroyo-Garcia R, Shen KA, Mazier M, Meyers BC, Ochoa OE et al (1997) A transgenic mutant of Lactuca sativa (lettuce) with a T-DNA tightly linked to loss of downy mildew resistance. Mol Plant Microb Interact 10:970–977
Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G et al (2008) Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci USA 105:3727–3732
Schillberg S, Twyman RM, Fischer R (2005) Opportunities for recombinant antigen and antibody expression in transgenic plants—technology assessment. Vaccine 23:1764–1769
Stewart CN, Via LE (1993) A rapid CTAB DNA isolation technique useful for RAPD fingerprinting and other PCR applications. Biotechniques 14:748–749
Streatfield SJ (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 5:2–15
Twyman RM, Stoger E, Schillberg S, Christou P, Fischer R (2003) Molecular farming in plants: host systems and expression technology. Trends Biotechnol 21:570–578
Wang SW, Stevenson AL, Kearsey SE, Watt S, Bähler J (2008) Global role for polyadenylation-assisted nuclear RNA degradation in posttranscriptional gene silencing. Mol Cell Biol 28:656–665
Weigel D, Glazebrook J (2006) Cold Spring Harb. Protoc. doi:10.1101/pdb.prot4666
Zavaglia C, Severini R, Tinelli C, Franzone JS, Airoldi A, Tempini S et al (2000) A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci 45:690–696
Acknowledgement
The authors are grateful to Professor ZongDong Qiao (Shanghai Jiao Tong University) for providing help on protein biological activity assay. This work was financially supported by China “863” High-Tech Program (2007AA100503), National Science Foundation (30871722), and Shanghai Science and Technology Committee (03DZ19310 and 073158202).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cui, L., Chen, Y., Shen, G. et al. Expression of Bioactive Thymosin Alpha 1 (Tα1) in Marker-free Transgenic Lettuce (Lactuca sativa). Plant Mol Biol Rep 29, 466–472 (2011). https://doi.org/10.1007/s11105-010-0246-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11105-010-0246-5